Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Endo Will Commence All-Cash Tender Offer Shortly Tender Offer Expected to be Completed in September PATTERSON, N.Y., Aug. 9, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO)...
-
PATTERSON, N.Y., Aug. 4, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today reported financial results for the three and six months ended June 30, 2010. For the second quarter of...
-
PATTERSON, N.Y., Aug. 2, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that its Board of Directors has approved certain changes to the Company's corporate...
-
PATTERSON, N.Y., July 28, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that Jennifer Good, President and Chief Executive Officer of Penwest, will be presenting at...
-
PATTERSON, N.Y., July 27, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) will conduct a conference call on Wednesday, August 4, at 11:00 a.m. EDT to review its financial results...
-
PATTERSON, N.Y., June 30, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that IVS Associates, Inc., the independent inspector of election for the Company's Annual...
-
PATTERSON, N.Y., June 22, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced the preliminary results of its Annual Meeting of Shareholders, which was held today. The...
-
PATTERSON, N.Y., June 17, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today issued an open letter to its shareholders in connection with its annual meeting this coming Tuesday,...
-
Issues "Proxy Alert" Advising Shareholders to Vote on the White Company Proxy Card for Two Incumbent Directors Maintains Conclusion That Turning Over Control to Tang-Edelman is Not...
-
PATTERSON, N.Y., June 14, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that in reports issued late Friday by RiskMetrics Group and Proxy Governance regarding the...